Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension

S. M. Jin, S. W. Park, K. H. Yoon, K. W. Min, K. H. Song, K. S. Park, J. Y. Park, I. B. Park, C. H. Chung, Sei-Hyun Baik, S. H. Choi, H. W. Lee, I. K. Lee, D. M. Kim, M. K. Lee

Research output: Contribution to journalLetterpeer-review

10 Citations (Scopus)

Fingerprint Dive into the research topics of 'Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension'. Together they form a unique fingerprint.

Medicine & Life Sciences